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The colorectal adenoma–carcinoma sequence describes the
sequential development of cancer starting with aberrant crypt foci
(ACF), which are supposed to be putative preneoplastic lesions
(Pretlow et al, 1991). The consecutive step is thought to be the
development of adenomas, which further increase in size and may
finally develop to adenocarcinomas. This transition from benign
precursors to malignant lesions is associated with the accumula-
tion of genomic defects (Fearon et al, 1990). Thus, molecular
analysis has identified inherited and somatic mutations that predis-
pose to colon cancer (e.g. mismatch repair genes, APC, K-ras and
p53). Defined molecular alterations have been linked to tumour
progression in the cascade of histologically detectable lesions (for
a recent review of the current models see Boland et al, 1998). Most
recently, genetic abnormalities and microsatellite instability in
colorectal cancer have been investigated in a large number of
patients (Iniesta et al, 1998). There are, however, only sporadic
data about genomic alterations in multiple lesions appearing
synchronously in the same patient. Thus, we investigated multiple
left-sided, synchronous lesions exploiting the fact that these
lesions are embedded in the same environment and are exposed to
almost identical influences. The investigated lesions included
ACF, multiple adenomas of various sizes, adenocarcinomas, and
one patient with additional liver metastasis. Using different mole-
cular techniques, we evaluated microsatellite instabilities and
mutations of APC, H-ras, K-ras, p53, DCC, and the DNA repair
genes hMLH1/hMSH2.
MATERIALS AND METHODS
To exclude any influence of tumor location as described for
microsatellite instability, left-sided colon carcinomas were chosen
for this study (Thibodeau et al, 1993). According to Bufill (1990),
tumours located in the transverse colon nearby the splenic flexure
were classified as being left-sided. ACF were located at least
10 cm away from the carcinoma.
Patient characteristics
Patient 1
An 82-year-old woman with a 2 cm polypoid adenocarcinoma of
the sigmoid (G1; pT1pN0pM0; Dukes’ stage A) without adenoma,
but several ACF.
Patient 2
A 47-year-old man with a 5 cm polypoid adenocarcinoma of the
sigmoid (G1; pT3pN0pM0: Dukes’ stage B). The tumour showed
a mucinous component and presented lymphangiosis. In the
rectum, a 1 cm tubulovillous adenoma with mild dysplasia was
detected.
Patient 3
A 71-year-old woman with a 2 cm ulcerated adenocarcinoma of
the rectum (G1; pT3pN0pM0; Dukes’ stage B) presented a
tubulovillous adenoma with moderate dysplasia (1 cm), and ACF
located in the sigmoid.
Patient 4
A 27-year-old man with multiple colonic adenomas, and a 3 cm
ulcerated adenocarcinoma of the rectum with regional lymph node
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metastases (G1; pT2pN1pMo; Dukes’ stage C). In addition, less
than 100 microadenomas and four larger tubulovillous adenomas
with following characteristics were detected: adenoma 1 (3 cm in
diameter) and adenoma 2 (2 cm in diameter) in the colon descen-
dens, both with moderate dysplasia; adenoma 3 (1 cm in diameter)
in the sigmoid, and adenoma 4 (0.5 cm in diameter) in the distal
colon transversum (near splenic flexure), both with mild dysplasia.
Patient 5
A 56-year-old man with 3 cm ulcerated adenocarcinoma of the
colon descendens (G1; pT3pN1pMo; Dukes’ stage C) with muci-
nous component. The regional lymph nodes were metastasized.
Co-existent with the carcinoma, several ACF and two tubulovil-
lous adenomas located in the colon descendens (1 cm and 0.5 cm
diameter, both with mild dysplasia) were found.
Patient 6:
A 66 year old man with a 5 cm ulcerated adenocarcinoma located
in the distal third of the colon transversum near the splenic flexure
(G1; pT4pN2pM1; Dukes’ stage D), several ACF, and a tubulovil-
lous adenoma with severe dysplasia in the colon descendens
(1.5 cm). In addition to metastases of the regional lymph nodes,
liver metastases were also present.
Handling of tissue specimens
A total of 30 native tissue samples was obtained immediately after
removal from six patients with colorectal neoplasms who under-
went surgical routine intervention. Tissue strips of grossly normal
mucosa of the resection margin were separated from uninvolved
submucosa and muscularis propria. Tumour tissue was prepared
from tubulovillous adenomas, colonic adenocarcinomas and, in
one patient, from liver metastases of the corresponding colonic
cancer. ACF were identified in whole mount preparations by
staining the grossly normal colonic mucosa with methylene blue
staining as previously described (Pretlow et al, 1991). ACF were
distinguished from normal crypts by their deeper colour, larger
size and round-oval shape of the luminal opening. Microdissection
of ACF was performed on methylene blue-stained mucosa using a
photomacroscope (Wild Heerbrugg, model M 400; Switzerland).
Histologically, ACF did not present dysplasia. Regional
tumour-free lymph nodes were dissected from pericolonic tissue
and were cleared from fatty tissue. For histopathologic examina-
tion, specimens were fixed in formalin. Five-micrometres serial
sections of the paraffin-embedded material were stained with
haematoxylin and eosin. All carcinomas examined were well
differentiated adenocarcinomas of the colon. The tubulovillous
adenomas presented a degree of dysplasia from mild to severe
(Table 1).
As reference samples for tumour specimens, histopathologically
tumour-free colonic mucosa, muscularis propria and lymph nodes
of the same patient were used. To avoid cross contamination, each
tissue sample was resected with freshly sterilized instruments.
Specimens were immersed into cell culture medium without
fetal calf serum (RPMI-1640) and processed immediately. The
specimens were divided into aliquots, shock frozen in a mixture
of ethanol/dry ice, and were stored at –80°C until nucleic acid
isolation. In addition, corresponding parts of all tissue samples
intended for molecular analysis were paraffin-embedded for
histopathologic examination.
Isolation of genomic DNA
Frozen tissue was pulverized in a mortar cooled with liquid
nitrogen. From this fine powder, genomic DNA was isolated using
Genomix (Talent, Trieste, Italy). After photometric evaluation,
genomic DNA was diluted to a final concentration of 0.2 mg ml–1 in
diethylpyrocarbonate-treated water and stored at –20°C.
Analysis of dinucleotide repeat polymorphisms
Polymorphisms of CA repeat motifs were evaluated on chromo-
somes 2, 5, 17 and 18. On chromosome 2, CA repeat motifs on loci
D2S123, D2S134 and D2S177 (Weissenbach, 1992a, 1992b,
1992c) proximal to the human DNA repair gene hMSH2 were
amplified by polymerase chain reaction (PCR) using the following
primers: D2S123, + strand: AAA CAG GAT GCC TGC CTT TA,
– strand: GGA CTT TCC ACC TAT GGG AC; D2S134, + strand:
AAC GTC TGC TCG TCA GAG TC; – strand: CGA CTA CGT
Table 1 Characteristics of tumours
Patient no. Adenocarcinoma Adenoma
Anatomical Æ Gross Staging Dukes’ Anatomical Æ Degree of
segment (cm) Grading stage segment (cm) dysplasia
1 Sigmoid 2 Polypoid pT1N0M0 A – – –
G1
2 Sigmoid 5 Polypoid pT3N0M0 B Rectum 1 Mild
G1
3 Rectum 2 Ulcerated pT3N0M0 B Sigmoid 1 Moderate
G1
4 Rectum 3 Ulcerated pT2N1M0 C Descending 3 No. 1: moderate
G1 Descending 2 No. 2.: moderate
Sigmoid 1 No. 3.: mild
Transverse 0.5 No. 4.: mild
5 Descending 3 Ulcerated pT3N1M0 C Descending 1 No. 1.: mild
G1 0.5 No. 2.: mild
6 Transverse 5 Ulcerated pT4N2M1 D Descending 1.5 Severe
G1
ND = not detected, Æ = diameter in centimetres, – = no material available.1278 R Sedivy et al
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GCT GGC TAC TT; D2S177, + strand: AGC TCA GAG ACA
CCT CTC CA; – strand: CTG TAT TAG GAT ACT TGG CTA
TTG A. PCR was done as described below for the amplification of
p53 using Taq-polymerase (Perkin-Elmer, Foster City, CA, USA)
instead of Ampli Taq Gold-polymerase. With the exception of the
primer annealing temperature, the cycling conditions were iden-
tical to those of p53 (D2S123: 54°C; D2S134: 58°C; D2S177:
55°C).
On chromosome 5, dinucleotide repeat motifs on loci D5S82
(Breukel et al, 1991a), D5S122 (Breukel et al, 1991b) and D5S346
(Spirio et al, 1991) proximal to the APC gene were amplified by
PCR according to the literature.
On chromosome 17, a CA repeat motif (Jones and Nakamura,
1992) and a pentanucleotide repeat motif (Cawkwell et al, 1994)
proximal to the p53 gene were analysed.
On chromosome 18, a CA repeat motif on loci D18S34 (Weber
and May, 1990) proximal to the DCC gene and an intragenic
sequence containing a variable number of tandem repeats termed
DCC-VNTR (Maesawa et al, 1995) were analysed. PCR products
were then analysed on 7% polyacrylamide gels in 1 ´ TBE buffer
and stained with ethidium bromide. Polymorphisms and deletions
were determined by comparison of tumour samples with normal
colonic tissue of the same patient.
Single-strand conformation polymorphism of DCC and
p53
Codons 138–473 of the DCC gene were amplified using four
different pairs of primers and analysed according to the method of
Miyake and co-workers (Miyake et al, 1994).
Similarly, exons 5–8 of p53 were amplified using the following
intron-specific primers: exon 5, + strand: CTT TCA ACT CTG
TCT CCT TCC TCT TCC TAC; exon 5, – strand: CTA AGA GCA
ATC AGT GAG GAA TCA GAG G (PCR product: 297 bp); exon
6, + strand: CTG ATT CCT CAC TGA TTG CTC TTA GGT C;
exon 6, – strand: CTG TGC AAT AGT TAA ACC CAT TTA CTT
TGC (PCR product: 293 bp); exon 7, + strand: TGT TAT CTC
CTA GGT TGG CTC TGA CTG TAC; exon 7, – strand: ATG
AGA GGT GGA TGG GTA GTA GTA TGG AAG (PCR product:
242 bp); exon 8, + strand: TGG TAA TCT ACT GGG ACG GAA
CAG C; exon 8, – strand: CTT CTT GTC CTG CTT GCT TAC
CTC G (PCR product; 158 bp).
Amplification of the target sequences was carried out in a total
volume of 50 ml containing the following reagents: 10 mM
Tris–HCl (pH 8.3), 50 mM potassium chloride (KCl), 1.5 mM
magnesium chloride (MgCl2), 0.001% (w/v) gelatine, 0.25 mM of
the forward and reverse primer, respectively, 0.5 mg genomic
DNA, 0.2 mM dNTPs, 1.5 U Ampli Taq Gold-polymerase (Perkin-
Elmer), overlaid with 50 ml mineral oil. In addition, the detergent
W1 (0.05%; Gibco-BRL, Gaithersburg, MD, USA) was used when
amplifying the exons of p53. Polymerase was activated by heat
(10 min at 95°C). Then, 35–40 cycles were accomplished with a
denaturation temperature of 94°C (1 min), annealing at 65°C
(1 min) and extension at 72°C (30 s). After completion of the PCR
cycles, the last extension time was 10 min at 72°C.
Successful amplification of DCC and p53 was confirmed by gel
electrophoresis (1% agarose, Seakem GTG, Rockland, ME, USA)
in 1 ´ TBE buffer, pH 8.0. For single-strand conformation poly-
morphism (SSCP) of both genes p53 and  DCC, amplification
products were denatured in a formamide buffer (10 min at 95°C,
rapidly cooled on ice), analysed on 10% polyacrylamide gels in
1 ´ TBE buffer, and evaluated after silver staining.
Heteroduplex analysis of APC, DCC and p53
Heteroduplex analysis of the APC gene (fragments E, F and G of
exon 15) was done as previously described (Friedl et al, 1993). For
heteroduplex analysis of DCC and p53, one additional denaturing
step was performed after completion of the PCR cycles (3 min at
99°C). Formation of heteroduplices was favoured by controlled
cooling from 99°C to 10°C below the corresponding annealing
temperature (0.6°C/min). Heteroduplices of APC, DCC and p53
were separated on 10% polyacrylamide gels in 1 ´ TBE buffer, and
visualized by staining with Sybr Green I (Molecular Probes,
Eugene, OR, USA) and epi-illumination at 254 nm wavelength.
Sequencing of DCC
Following the Ampli cycle sequencing kit protocol (Perkin-
Elmer), direct dideoxy-sequencing of the PCR products was
performed on an automated DNA-Sequencer (Alf, Pharmacia,
Uppsala, Sweden) using the 5¢ terminally fluorescein isothio-
cyanate (FITC)-labelled sense or antisense strand PCR primers.
Prior to sequencing, excess PCR-primers were digested using a
mixture of 5 U exonuclease 1 and 5 U alkaline phosphatase
(Amersham Life Sciences, Little Chalfont, UK).
Restriction fragment length polymorphism of K-ras and
H-ras
Mutations of K-ras (codons 12 and 13 of the first exon) and H-ras
(codon 12 of the first exon) were evaluated by restriction fragment
length polymorphism (RFLP) as previously described (Jiang et al,
1989). Briefly, exon 1 of K-ras and H-ras was amplified from
gDNA of tumour samples and normal colonic mucosa by PCR.
Mutations of K-ras were detected by agarose gel electrophoresis
after digestion of the PCR products with BstNI (codon 12) or HphI
(codon 13) respectively. Similarly, mutations of H-ras were
detected using MspI (codon 12).
Protein truncation test for hMLH1 and hMSH2
Using an in vitro transcription/translation assay, protein truncating
mutations of the mismatch repair genes hMLH1 and hMSH2 were
detected as previously described (Luce et al, 1995). Briefly, the
coding sequence of the target was amplified by reverse transcrip-
tion PCR (RT-PCR) using a + strand primer with a T7 promoter
sequence and a translation initiation site, from which the protein
was synthesized (reticulocyte lysate system, Promega, Madison,
WI, USA). The tritiated protein ([3H]-leucine) was analysed on a
12.5% SDS-polyacrylamide gel using Amplify (Amersham) to
enhance the signal intensity.
RESULTS
Investigating nine microsatellite markers, none of the malignant
lesions showed microsatellite instability. It was thus concluded
that all tumours were replication error phenotype negative
(RER–).Mutations of patients with multiple colonic tumours 1279
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Chromosome 2 (hMSH2)
Analyses of microsatellites of hMSH2 showed deletions in the
tissue samples of the malignant tumour in one allele of patient 1
(locus D2S123) and patient 2 (D2S177, D2S134). In the protein
truncation test, however, both patients showed physiologic
hMSH2 proteins.
Chromosome 3 (hMLH1)
Using the protein truncation test, aberrant proteins of hMLH1 were
not detected in these specimens.
Chromosome 5 (APC)
Using heteroduplex analysis, we did not find any mutation in hot
spot areas of the APC gene (exon 15, fragments E–G), but several
deletions including the entire genomic region of the CA-repeats.
Two deletions were detected in the adenoma of patient 2 (D5S82,
D5S346), whereas the cancerous tissue did not reveal genomic
alterations. In patient 3, the same deletions of microsatellites were
found in adenomatous and cancerous tissue (D5S122, D5S346).
Similarly, patient 4 presented two deletions of microsatellite
regions in the adenocarcinoma, but only in one of the adenomas
(D5S82, D5S346). The remaining three adenomas did not show
loss of heterozygosity (LOH) on chromosome 5 (Figure 1). In
patient 5, a deletion in the cancerous tissue was detected in one
microsatellite locus (D5S82), whereas the adenoma appeared
inconspicuous. Patient 6 presented no deletion at all.
Chromosome 11 (H-ras)
None of the tissue samples showed mutations on codon 12 of the
first exon of H-ras.
Chromosome 12 (K-ras)
Point mutations of one allele were detected at codon 12 of the K-
ras gene in patients 1 and 2. This mutation was observed in the





   
Figure 1 Chromosome 5: dinucleotide repeats at the APC locus (D5S346,
patient 4). Legend: 100 bp ladder (M), normal mucosa (lane 1), adenoma no.
1 (lane 2), adenoma no. 2 (lane 3), adenoma no. 3 (lane 4), adenoma no. 4
(lane 5), carcinoma (lane 6). Deletion of one allele is observed in adenoma
no. 4 (lane 5) and the carcinoma (lane 6)




Figure 2 Chromosome 12: RFLP of K-ras, codon 12 of exon 1 (patient 2).
Legend: 100 bp ladder (M), normal mucosa (lane 1: PCR product; lane 2:
PCR product digested with BstNI), ACF (lane 3: PCR product; lane 4: PCR
product digested with BstNl), adenoma (lane 5: PCR product; lane 6: PCR
product digested with BstNl), carcinoma (lane 7: PCR product; lane 8: PCR
product digested with BstNl), CaCo2 (lane 9: PCR product; lane 10: PCR
product digested with BstNl), CCL 228 (lane 11: PCR product; lane 12: PCR
product digested with BstNl), negative control (lane 13). The PCR product of
157 bp is digested twice in the case of wild-type K-ras yielding fragments of
114 bp, 29 bp and 14 bp (the small fragments are not visible on the gel).
Mutation on codon 12 suppresses one restriction site thus yielding fragments
of 143 bp and 14 bp after digestion with BstNI. The tumour cell line CaCo2
served as positive control (both alleles mutated), whereas CCL 228 has the
wild-type sequence on codon 12




Figure 3 Chromosome 17: pentanucleotide repeats at the p53 locus
(patient 6). Legend: 100 bp ladder (M), normal mucosa (lane 1), ACF (lane
2), adenoma (lane 3), carcinoma (lane 4), normal liver (lane 5), liver
metastasis (lane 6). Deletion of one allele is observed in the carcinoma (lane
4) and the liver metastasis (lane 6)1280 R Sedivy et al
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adenocarcinoma as well as in the adenoma of patient 2 (Figure 2).
In patient 1, only the adenocarcinoma was affected. Codon 13 of
K-ras was not mutated in these specimens.
Chromosome 17 (p53)
Assaying SSCP as well as the formation of heteroduplices, we did
not find mutations in hot spots of the p53 gene (exons 5–8). In
contrast to all four adenomas, a deletion within the penta-
nucleotide motif (p53–5) was observed in patient 4. LOH of the
dinucleotide (p53–2) was found in the adenocarcinoma of patient
3. In patient 6, both motifs (p53–2 and p53–5) were deleted in
cancerous and metastatic tissue, whereas only the dinucleotide
repeat p53–2 was deleted in the adenoma (Figure 3).
Chromosome 18 (DCC)
No mutations were detected in codons 138–473 of the DCC gene
by means of sequencing. Patients 1 and 2 manifested the wild-type
gene of DCC and that of locus D18S34. Patients 3 and 4 presented
one deletion in both the carcinoma and the adenoma. In patient 5,
LOH of DCC in the adenocarcinoma was found. In patient 6 one
allele of the DCC gene was deleted in the adenoma, whereas in the
adenocarcinoma a corresponding deletion affected the other allele.
It was noteworthy that the tissue of the metastasis showed the
same pattern as observed in the carcinoma (Figure 4).
Sequence of genetic alterations
The study of ACF did not identify lesions with genomic alter-
ations. In patients 1 and 5, genetic defects were detected in the
carcinoma only, but never in the precursor lesions. Accumulation
of genetic aberrations was observed in patient 3, whose tumours
presented allelic loss at APC- and DCC-associated loci in both the
adenoma and the carcinoma. In addition, the adenocarcinoma
showed two deleted regions of CA-repeats in proximity to the p53
gene. The adenocarcinoma of patient 4 manifested five deletions,
three of them also observed in the benign polyps. In contrast, inde-
pendent tumorigenesis is suggested by the data of patients 2 and 6
by comparing the adenoma with the carcinoma. Although the co-
existently appearing adenoma showed deletions within the DCC
gene, different alleles were affected in patient 6. In patient 2, we
found similar defects in the carcinoma and the adenoma on
chromosome 12 (K-ras), but different deleted CA-repeats in the
adenoma and carcinoma (Table 2).
DISCUSSION
In our study, we investigated different synchronous lesions of the
adenoma–carcinoma sequence of the colon. By applying SSCP,
heteroduplex analysis, RFLP, sequencing and protein truncation
tests, we studied a total of 25 loci relevant for mutational alter-




Figure 4 Chromosome 18: variable number of tandem repeats at the DCC
locus (patient 6). Legend: 100 bp ladder (M), normal mucosa (lane 1), ACF
(lane 2), adenoma (lane 3), carcinoma (lane 4), normal liver (lane 5), liver
metastasis (lane 6). The position of the alleles is marked by the double arrow
showing the deletion of different alleles when comparing the adenoma and
the carcinoma
Table 2 Genetic alterations observed in adenomas and carcinomas
Patient
Adenocarcinoma Adenoma
no. hMSH2a hMLH1 APC K-ras p53 DCC hMSH2 hMLH1 APC K-ras p53 DCC
1 LOH ND ND MUT ND ND – – – – – –
2 LOH ND ND MUT ND ND ND ND LOH MUT ND ND
3 ND ND LOH ND LOH LOH ND ND LOH ND ND LOH
4 ND ND LOH ND LOH LOH ND ND No. 1: ND ND ND LOH
No. 2: ND ND ND ND
No. 3: ND ND ND ND
No. 4: LOH ND ND ND
5 ND ND LOH ND ND LOH ND ND No. 1: ND ND ND ND
No. 2: ND ND ND ND
6 ND ND ND ND LOH LOH ND ND ND ND LOH LOH
allele a allele b
ND = not detected, – = no material available, LOH = Loss of heterozygosity, MUT = Mutation of codon 12 on K -ras. aAlthough LOH was observed in proximity to
the hMSH2 locus, the repair protein was normal in the protein truncation test.ations, potential deletions and microsatellite instabilities. We
looked for these genetic alterations in ACF, adenomas differing in
size and grade of dysplasia and adenocarcinomas with identical
degree of differentiation. According to the adenoma-carcinoma
sequence described by Fearon and Vogelstein (1990), we found an
escalation of genetic aberrations in four of six patients when
assaying synchronous lesions of the colon. All carcinomas were
affected more frequently when compared with the corresponding
adenomas. Although we investigated 25 different genetic markers,
we were not able to unravel genetic differences between ACF and
normal mucosa. This might indicate the presence of hidden muta-
tions in not typical loci. The investigated ACF did not present any
dysplasia. Recently, two pathways for the further development of
ACF were described (Gregorio et al, 1997): one direction leads to
dysplastic ACF, which are thought to develop in adenomas; the
other direction describes the development to hyperplastic polyps.
Thus, the absence of genetic alterations in our ACF is compatible
with the latter hypothesis, which describes non-dysplastic ACF as
precursors of hyperplastic polyps rather than of adenomas.
According to the adenoma–carcinoma sequence one would
expect an increase of genetic alterations with size and decreasing
differentiation of the lesions. Patient 4 with multiple colonic
adenomas presented four larger adenomas differing in size and in
degree of dysplasia. Only the smallest adenoma with mild
dysplasia showed LOH in microsatellite regions of APC-associ-
ated loci (D5S82, D5S346), present also in the corresponding
carcinoma of the rectum. In the largest and moderately differenti-
ated adenoma, allelic deletion of the DCC-VNTR locus was
detected. In contrast, the remaining intermediately sized adenomas
were not genetically altered. In patient 6, the adenocarcinoma and
the adenoma presented deletions of the DCC gene, but different
alleles were affected. The liver metastasis showed the identical
pattern as observed in the primary carcinoma.
In accordance with the suggested adenoma–carcinoma sequence
of the colon, four patients reflected the progressive accumulation of
genetic defects in synchronously appearing tumours during
carcinogenesis. However, two patients with non-hereditary malig-
nomas presented different genetic instabilities in different but
synchronously appearing tumours, which indicates independent
and simultaneous tumorigenesis within the same organ (Table 3).
According to the linear model of colorectal carcinogenesis we
assume that ACF and adenomas hide unknown genetic aberrations
different from the investigated 25 loci. This study shows 
that although different tumours arise in an almost identical
environment, their development is individual and linked to differ-
ential genetic alterations.
Disregarding hitherto unknown genetic mutations, we found in
our study variations not compatible with linear models of carcino-
genesis. Along this line, chaodynamical models were suggested
recently to describe carcinogenesis by non-linear models (Schwab
and Pienta, 1996; Sedivy, 1996a; Posadas et al, 1996; Coffey,
1998; Ferreira et al, 1998; Waliszewski et al, 1998). If this is the
case, we propose non-linear models to explain the obtained hetero-
geneity observed in our results. Genetic instability among cells
produces a tremendous and chaotic diversity that may lead to
cancer (Coffey, 1998). From a holistic point of view, not only
genetic events may drive the onset of cancer as suggested by
Waliszewski (1998). In biology, deterministic and non-determin-
istic phenomena co-exist. Alterations of the dynamic cellular
network and thermodynamic instability may contribute to the
development of cancer (Waliszewski, 1997). The resulting
unstable stationary state facilitates the chaotic dynamics leading to
the fractal appearance of tumours (Cross, 1994; Sedivy, 1996b;
Waliszewski, 1997). Chaotic diversity permits the tumour to
produce a cell clone able to escape therapeutic influences (Coffey,
1998) as shown for prostate cancer (Posadas et al, 1996). Thus,
understanding cancer as a complex adaptive system (Schwab and
Pienta, 1996) and by means of chaos theory will help to establish
new therapeutic concepts (Sedivy and Mader, 1997).
By finding low-level aberrations in the carcinoma of patient 2
(genetic instability on loci D2S177, D2S134; mutation of K-ras
exon 12), which probably are not sufficient for malignant trans-
formation, non-linear models of carcinogenesis might be applied.
Although we investigated only a few patients, the observed
exceptions urges additional explanations, if no hidden mutations
exist.
In conclusion, in our study we found in synchronously
appearing neoplastic lesion of the colon hints for the linear and
clonal development of cancer. In contrast to this widely acclaimed
model, we observed exceptions that either contain unknown
genetic defects or might be explainable by a non-linear and holistic
approach. Nevertheless, the small number of patients precludes
detailed explanations. The trend of this data, however, urges to
include alternative sights such as chaodynamical perspectives,
which might help to understand these exceptions. Noteworthy, it is
typical for chaodynamical processes that they appear at first sight
as pure stochastic processes, but further investigations uncover
their non-linear nature at least.
Mutations of patients with multiple colonic tumours 1281
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Table 3 Overview of genetic alterations observed in different types of tissue
Patient no. Normal ACF Adenoma Carcinoma Metastasis
mucosa
1 None None – hMSH2, K-ras –
2 None None APC, K-ras hMSH2, K-ras –
3 None None APC, DCC APC, p53, DCC –




5 None None No. 1: none APC, DCC –
No. 2: none
6 None None p53, DCCallele b p53, DCCallele a p53, DCCallele a
– = no material available.1282 R Sedivy et al
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